Searched over 200M research papers for "massive cva"
5 papers analyzed
These studies suggest that patients with giant cell arteritis have a significantly increased risk of cerebrovascular accident compared to non-GCA controls.
20 papers analyzed
Cerebrovascular accidents (CVA), commonly known as strokes, are a significant cause of morbidity and mortality worldwide. They occur when the blood supply to a part of the brain is interrupted or reduced, preventing brain tissue from getting oxygen and nutrients. This can lead to brain damage and loss of function.
Giant cell arteritis (GCA) is an inflammatory disease of blood vessels, most commonly involving large and medium arteries of the head. A systematic review and meta-analysis of cohort studies have shown that patients with GCA have a significantly increased risk of experiencing a CVA. The pooled risk ratio of CVA in patients with GCA compared to non-GCA controls was found to be 1.40, indicating a 40% higher risk. This highlights the importance of monitoring and managing cardiovascular health in patients with GCA to mitigate the risk of stroke.
Recent studies have also explored the role of immune cells, particularly neutrophils, in the context of CVA and related conditions. For instance, Coxsackievirus A6 (CVA6) infection has been linked to myocardial injury, which is often accompanied by massive neutrophil infiltration. This suggests that excessive neutrophils may contribute to tissue damage and inflammation, exacerbating the severity of the condition. Understanding the involvement of neutrophils in such injuries can provide new insights into potential therapeutic strategies to reduce inflammation and tissue damage in CVA and related conditions.
Massive cerebrovascular accidents are a critical health issue, particularly in patients with underlying conditions such as giant cell arteritis. The increased risk of CVA in these patients underscores the need for vigilant cardiovascular monitoring and management. Additionally, the role of neutrophils in exacerbating myocardial injury and potentially influencing CVA outcomes highlights the importance of further research into immune cell-mediated therapies. By addressing these factors, we can improve prevention and treatment strategies for those at risk of massive CVA.
Most relevant research papers on this topic